【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Avonex/Rebif
04.1.2 Plegridy
04.1.3 Tecfidera
04.1.4 Tysabri
04.1.5 Comtan
04.1.6 Stalevo
04.1.7 Exelon/Exelon Patch
04.1.8 Extavia
04.1.9 Gilenya
04.1.10 Cerebyx
04.1.11 Dilantin-125
04.1.12 Lyrica
04.1.13 Neurontin
04.1.14 Zarontin
04.1.15 Azilect
04.1.16 Copaxone
04.1.17 Keppra/Keppra XR
04.1.18 Neupro
04.1.19 Vimpat
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08.Segmentation of Global Neurodegenerative Diseases Market by Type of Disease
09.Global Multiple Sclerosis Market
09.1 Multiple Sclerosis: Overview
09.1.1 About the Disease
09.1.2 Symptoms
09.1.3 Etiology
09.1.4 Epidemiology
09.1.5 Economic Burden
09.2 Market Overview
09.3 Market Size and Forecast
09.4 Multiple Sclerosis Market in US
09.4.1 Market Size and Forecast
10.Global Alzheimer’s Disease Market
10.1 Alzheimer’s Disease: Overview
10.1.1 About the Disease
10.1.2 Dementia
10.1.3 Epidemiology and Forecast
10.1.4 Types of Dementia
10.1.5 Global Burden
10.1.6 Etiology
10.1.7 Cost of Care
10.1.8 Alzheimer’s Disease and Caregiving
10.2 Market Overview
10.3 Market Size and Forecast
11.Global Epilepsy Market
11.1 Epilepsy: Overview
11.1.1 About the Disease
11.1.2 Etiology
11.1.3 Types of Epilepsy
11.1.4 Symptoms
11.1.5 Epidemiology
11.1.6 Economic Burden
11.2 Market Overview
11.3 Market Size and Forecast
11.4 Epilepsy Market in US
11.4.1 Market Size and Forecast
11.5 Epilepsy Market in Europe
11.5.1 Market Size and Forecast
11.6 Epilepsy Market in Japan
11.6.1 Market Size and Forecast
12.Global Parkinson’s Disease Market
12.1 Parkinson’s Disease: Overview
12.1.1 About the Disease
12.1.2 Symptoms
12.1.3 Etiology
12.1.4 Epidemiology
12.1.5 Economic Burden
12.2 Market Overview
12.3 Market Size and Forecast
13.Global Huntington’s Disease Market
13.1 Huntington’s Disease: Overview
13.1.1 About the Disease
13.1.2 Symptoms
13.1.3 Etiology
13.1.4 Prevalence of Huntington’s Disease
13.1.5 Pipeline Portfolio
13.1.6 Economic Burden
13.2 Market Overview
13.3 Market Size and Forecast
14.Global Amyotrophic Lateral Sclerosis Market
14.1 Amyotrophic Lateral Sclerosis: Overview
14.1.1 About the Disease
14.1.2 Types of Amyotrophic Lateral Sclerosis
14.1.3 Etiology and Pathophysiology
14.1.4 Symptoms
14.1.5 Epidemiology
14.1.6 Diagnosis
14.1.7 Pipeline Portfolio
14.2 Market Overview
14.3 Market Size and Forecast
15.Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule
15.1 Biologics
15.2 Small Molecules
16.Segmentation of Global Neurodegenerative Diseases Market by Route of Administration
16.1 Oral
16.2 Parenteral
16.3 Topical
17.Geographical Segmentation
18.Buying Criteria
19.Market Growth Drivers
20.Drivers and their Impact
21.Market Challenges
22.Impact of Drivers and Challenges
23.Market Trends
24.Trends and their Impact
25.Vendor Landscape
25.1 Competitive Scenario
25.1.1 Key News
25.1.2 Mergers and Acquisitions
25.2 Market Share Analysis 2014
25.2.1 Competitive Assessment of Major Drugs
25.2.2 Biogen Idec
25.2.3 Pfizer
25.2.4 Teva Pharmaceutical
25.2.5 Novartis
25.2.6 Merck Serono
25.2.7 UCB
25.3 Other and Potential Future Prominent Vendors
26.Key Vendor Analysis
26.1 Biogen Idec
26.1.1 Key Facts
26.1.2 Business Overview
26.1.3 Business Segmentation by Revenue 2013
26.1.4 Geographical Segmentation by Revenue 2013
26.1.5 Business Strategy
26.1.6 Key Developments
26.1.7 SWOT Analysis
26.2 Merck Serono
26.2.1 Key Facts
26.2.2 Business Overview
26.2.3 Geographical Segmentation by Revenue 2013
26.2.4 Business Strategy
26.2.5 Recent Developments
26.2.6 SWOT Analysis
26.3 Novartis
26.3.1 Key Facts
26.3.2 Business Description
26.3.3 Business Segmentation
26.3.4 Revenue by Business Segmentation
26.3.5 Revenue Comparison 2012 and 2013
26.3.6 Sales by Geography
26.3.7 Business Strategy
26.3.8 Key Developments
26.3.9 SWOT Analysis
26.4 Pfizer
26.4.1 Key Facts
26.4.2 Business Overview
26.4.3 Business Segmentation by Revenue 2013
26.4.4 Business Segmentation by Revenue 2012 and 2013
26.4.5 Geographical Segmentation by Revenue
26.4.6 Business Strategy
26.4.7 Key Developments
26.4.8 SWOT Analysis
26.5 Teva Pharmaceutical
26.5.1 Key Facts
26.5.2 Business Overview
26.5.3 Business Segmentation
26.5.4 Business Segmentation by Revenue 2013
26.5.5 Business Segmentation by Revenue 2012 and 2013
26.5.6 Sales by Geography
26.5.7 Business Strategy
26.5.8 Key Developments
26.5.9 SWOT Analysis
26.6 UCB
26.6.1 Key Facts
26.6.2 Business Overview
26.6.3 Product Segmentation by Revenue 2013
26.6.4 Product Segmentation by Revenue 2012 and 2013
26.6.5 Geographical Segmentation by Revenue 2013
26.6.6 Business Strategy
26.6.7 Recent Developments
26.6.8 SWOT Analysis
27.Other Reports in this Series
List Of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Neurodegenerative Diseases Market 2014-2019 ($ million)
Exhibit 3: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease
Exhibit 4: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease 2014
Exhibit 5: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease 2019
Exhibit 6: Etiology of Multiple Sclerosis
Exhibit 7: Global Multiple Sclerosis Market 2014-2019 ($ million)
Exhibit 8: Multiple Sclerosis Market in US 2014-2019 ($ million)
Exhibit 9: Prevalence of Dementia by Geography 2013, 2030, and 2050 (million)
Exhibit 10: Prevalence of Dementia by Geography 2013-2018 (millions)
Exhibit 11: Types of Dementia and Associated Symptoms
Exhibit 12: Types of Dementia by Prevalence 2013
Exhibit 13: Segmentation of Economic Burden of Alzheimer’s Disease and Other Dementias by Geography 2013
Exhibit 14: Average Cost of Care for Americans Aged 65 and Above with Alzheimer’s Disease and Other Dementias 2013
Exhibit 15: Distribution of Alzheimer’s Caregivers by Age 2013
Exhibit 16: Projected Prevalence of Dependence 2010 and 2030
Exhibit 17: Global Alzheimer’s Disease Market 2014-2019 ($ million)
Exhibit 18: Global Epilepsy Market 2014-2019 ($ million)
Exhibit 19: Epilepsy Market in US 2014-2019 ($ million)
Exhibit 20: Epilepsy Market in Europe 2014-2019 ($ million)
Exhibit 21: Epilepsy Market in Japan 2014-2019 ($ million)
Exhibit 22: Global Parkinson’s Disease Market 2014-2019 ($ million)
Exhibit 23: Segmentation of Global Parkinson’s Disease Market by Country 2014
Exhibit 24: Snapshot of Disease
Exhibit 25: Prevalence of Huntington’s Disease by Geography 2013
Exhibit 26: Huntington’s Disease: Pipeline Portfolio
Exhibit 27: Global Huntington’s Disease Market 2014-2019 ($ million)
Exhibit 28: Snapshot of Disease
Exhibit 29: Amyotrophic Lateral Sclerosis: Pipeline Portfolio
Exhibit 30: Global Amyotrophic Lateral Sclerosis Market 2014-2019 ($ million)
Exhibit 31: Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule
Exhibit 32: Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule 2014
Exhibit 33: Segmentation of Global Neurodegenerative Diseases Market by Route of Administration
Exhibit 34: Segmentation of Global Neurodegenerative Diseases Market by Route of Administration 2014
Exhibit 35: Segmentation of Global Neurodegenerative Diseases Market by Geography 2014
Exhibit 36: Global Neurodegenerative Diseases Market Share Analysis 2014
Exhibit 37: Major Drugs for Neurodegenerative Diseases by Revenue 2014 ($ million)
Exhibit 38: YoY Revenue of Major Drugs for Neurodegenerative Diseases 2011-2014 ($ million)
Exhibit 39: Revenue Share of Major Drugs for Neurodegenerative Diseases 2011-2014
Exhibit 40: Biogen Idec: Global Revenue of Products 2011-2014 ($ million)
Exhibit 41: Biogen Idec: YoY Global Revenue of Avonex 2011-2014 ($ million)
Exhibit 42: Biogen Idec: Revenue of Avonex in US 2011-2014 ($ million)
Exhibit 43: Biogen Idec: Revenue of Avonex in ROW 2011-2014 ($ million)
Exhibit 44: Biogen Idec: YoY Global Revenue of Tysabri 2011-2014 ($ million)
Exhibit 45: Biogen Idec: Revenue of Tysabri in US 2011-2014 ($ million)
Exhibit 46: Biogen Idec: Revenue of Tysabri in ROW 2011-2014 ($ million)
Exhibit 47: Biogen Idec: YoY Global Revenue of Fampyra 2011-2014 ($ million)
Exhibit 48: Biogen Idec: Revenue of Plegridy in US and ROW 2014 ($ million)
Exhibit 49: Biogen Idec: Revenue of Tecfidera in US and ROW 2013 and 2014 ($ million)
Exhibit 50: Pfizer: YoY Global Revenue of Lyrica 2011-2014 ($ million)
Exhibit 51: Pfizer: YoY Global Revenue of Neurontin 2011-2013 ($ million)
Exhibit 52: Teva Pharmaceutical: YoY Global Revenue of Copaxone 2011-2014 ($ million)
Exhibit 53: Teva Pharmaceutical: Quarterly Revenue of Copaxone 2011-2014 ($ million)
Exhibit 54: Teva Pharmaceutical: YoY Global Revenue of Azilect 2011-2014 ($ million)
Exhibit 55: Teva Pharmaceutical: Quarterly Revenue of Azilect 2011-2014 ($ million)
Exhibit 56: Novartis: YoY Global Revenue of Gilenya 2011-2014 ($ million)
Exhibit 57: Novartis: Revenue of Gilenya in US and ROW 2011-2013 ($ million)
Exhibit 58: Novartis: YoY Global Revenue of Extavia 2011-2014 ($ million)
Exhibit 59: Novartis: YoY Global Revenue of Comtan/Stalevo 2011-2014 ($ million)
Exhibit 60: Novartis: Revenue of Comtan/Stalevo in US and ROW 2011-2013 ($ million)
Exhibit 61: Novartis: YoY Global Revenue of Exelon/Exelon Patch 2011-2014 ($ million)
Exhibit 62: Novartis: Revenue of Exelon/Exelon Patch in US and ROW 2011-2013 ($ million)
Exhibit 63: Merck Serono: YoY Global Revenue of Rebif 2011-2014 ($ million)
Exhibit 64: Merck Serono: Revenue of Rebif in North America 2011-2014 ($ million)
Exhibit 65: Merck Serono: Revenue of Rebif in Europe 2011-2014 ($ million)
Exhibit 66: Merck Serono: Revenue Share of Rebif by Region 2012-2014
Exhibit 67: UCB: YoY Global Revenue of Vimpat 2011-2014 ($ million)
Exhibit 68: UCB: YoY Revenue of Vimpat in Europe 2011-2014 ($ million)
Exhibit 69: UCB: YoY Revenue of Vimpat in North America 2011-2014 ($ million)
Exhibit 70: UCB: YoY Global Revenue of Keppra/Keppra XR 2011-2014 ($ million)
Exhibit 71: UCB: YoY Revenue of Keppra/Keppra XR in Europe 2011-2014 ($ million)
Exhibit 72: UCB: YoY Revenue of Keppra/Keppra XR in North America 2011-2014 ($ million)
Exhibit 73: UCB: YoY Global Revenue of Neupro 2011-2014 ($ million)
Exhibit 74: UCB: YoY Revenue of Neupro in Europe 2011-2014 ($ million)
Exhibit 75: UCB: YoY Revenue of Neupro in North America 2011-2014 ($ million)
Exhibit 76: Biogen Idec: Business Segmentation by Revenue 2013
Exhibit 77: Biogen Idec: Geographical Segmentation by Revenue 2013
Exhibit 78: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 79: Novartis AG: Business Segmentation
Exhibit 80: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 81: Novartis AG: Revenue by Business Segmentation 2012 and 2013 ($ million)
Exhibit 82: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 83: Pfizer: Business Segmentation by Revenue 2013
Exhibit 84: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 85: Pfizer: Geographical Segmentation by Revenue 2013
Exhibit 86: Teva Pharmaceutical Industries: Business Segmentation
Exhibit 87: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
Exhibit 88: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 89: Teva Pharmaceutical Industries: Sales by Geography 2013
Exhibit 90: UCB: Product Segmentation by Revenue 2013
Exhibit 91: UCB: Product Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 92: UCB: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル:神経変性疾患治療薬の世界市場:アルツハイマー型認知症、パーキンソン病、多発性硬化症、てんかん、ハンチントン病、筋萎縮性側索硬化症■ 英文:Global Neurodegenerative Diseases Market 2015-2019
■ 発行日:2015年5月6日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5793
■ 調査対象地域:グローバル
- 歯科インプラントの世界市場分析:製品別(チタン、ジルコニウム)、セグメント予測The global dental implants market is expected to be USD 6.81 billion by 2024, based on a new report by Grand View Research, Inc. Rising demand for tooth (or teeth) replacement has provided good growth potential to the market. Growing number of dental injuries owing to road accidents and sport injuries are also considered as some of the major factors favoring demand of implants. Growing aesthetic a …
- 造影剤の世界市場:ヨード造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブルOver the years, the contrast media/contrast agents market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide. These advancements have led to the improved use of many existing contrast agents as well as the introduction of new ones. In 2015, the iodinated contrast media/contrast agents are expected to account for the largest s …
- スマートTV用ジェスチャ認識ソリューションの世界市場2015-2019About Gesture Recognition in Smart TV A gesture is a movement of hands, fingers, arms, body, and face of an individual. The gesture of an individual is captured via a camera that takes it as an input. The input then passes through a number of mathematical algorithms that can be used to trace the gestures of the individual. As the extraction of the features takes place, an image is developed throug …
- MRSA(メチシリン耐性黄色ブドウ球菌)薬の世界市場2016-2020About Methicillin-Resistant Staphylococcus aureus (MRSA) MRSA is an infection of the skin that occurs mostly in hospitals and healthcare facilities. It is treated with commonly-used antibiotics and usually spreads from person to person by direct skin-to-skin contact. Physicians often find MRSA harder to treat than most other strains of Staphylococcus aureus because it is sometimes resistant to com …
- 2014年戦略提言:スペインの病院止血診断検査市場This new report from Venture Planning Group contains 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Spanish coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five yea …
- 電動洗浄機の世界市場2016-2020Covering: This market research report covers the growth prospects of the global electric power washer market with segmentation based on end users (residential and commercial) and region (Americas, Europe, APAC, and ROW). It also includes an insightful analysis of the leading vendors in this market, including Simpson, Generac, Karcher, and Snowjoe. The growing interest of homeowners to spruce up ba …
- 高圧ケーブルの世界市場:架空ケーブル、地中ケーブル、海底ケーブルThe global high voltage cables & accessories market is projected to grow at a CAGR of 6.0% during the forecast period, to reach USD 41.27 Billion by 2021. Offshore windfarms, high voltage direct current links, and grid interconnections are the major drivers of the high voltage cables & accessories market. Increasing need for grid interconnections is resulting in rising investments in the new subma …
- 透析(Dialysis)の世界市場予測The global dialysis market is broadly categorized into two segments, namely, hemodialysis (products & services) and peritoneal dialysis (products & services). The hemodialysis segment accounts for the larger share of the global market, while the peritoneal dialysis segment is expected to grow at a higher CAGR in the forecast period. The hemodialysis (HD) products and services market includes machi …
- 世界のスマート・セットトップボックス及びドングル市場動向(2014-2018)About Smart STBs and Dongles STB are devices that are connected to a TV at the user's premises. These devices enable the user to receive unencrypted subscribed channels through an addressable system for viewing encrypted channels. They connect a TV to an external signal source and transform the transmitted signal into video content, which is then displayed on the screen. A smart STB is the one whi …
- 世界の家庭用ロボット掃除機市場:Global Residential Robotic Vacuum Cleaner Market 2014-2018TechNavio forecasts the Global Residential Robotic Vacuum Cleaner Market 2014-2018 with a CAGR of 16.06 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of …
- 透明導電膜の世界市場予測(~2026):用途別(スマートフォン、タブレット、ノートパソコン、液晶表示ディスプレー、ウェアラブル機器)、材料別(ITOコーティングガラス、ITOコーティングPET、金属メッシュ、銀ナノワイヤ、カーボンナノチューブ)、地域別“Transparent conductive films market is projected to reach USD 8.46 billion by 2026”The transparent conductive films market is projected to reach USD 8.46 billion by 2026, at a CAGR of 9.4% from 2016 to 2026. Increasing use of transparent conductive films in smartphones, tablets, notebooks, LCDs, wearable devices, and other applications due to growing population and consumption of electronic displ …
- 世界のシステム・インフラ・ソフト市場(2012-2016)TechNavio's analysts forecast the Global System Infrastructure Software market to grow at a CAGR of 5.24 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of mobile devices. The Global System Infrastructure Software market has also been witnessing the increasing adoption of cloud-based system infrastructure software. However, th …
- 飼料用酵素の世界市場:フィターゼ、プロテアーゼ、非澱粉性多糖類Feed enzymes accelerate the biochemical reactions in animals in order to support life. These enzymes are added to the feed of pig, poultry, cattle, and aquatic animals to enhance production efficiency. The major function of feed enzymes is to increase the digestibility of animals; for instance, phytase is used in the animal feed to break down the protein consumed by animals, which enhances their d …
- 燃料の世界市場:ガソリン、ディーゼル、重質燃料油、ジェット燃料、灯油About the Fuels Market During combustion, the chemical energy of the fuel is converted into heat energy. Fuel is converted from one state to another (solid to liquid or gaseous) to enhance the energy released. Fuels can be classified into six major categories: • Liquid (crude oil and petroleum products) • Solid (coal and coal products) • Gas (natural gas) • Other fossil fuels • Peat • Biomass Tech …
- グリーン・キレート剤の世界市場2017-2021About Green Chelating Agents Chelating agents are substances that remove ions from a solution system, without reacting with it. They are also known as sequestering agents or complexing agents. Chelating agents are used as scale inhibitors and in cleaning products. The agents bind to ions of calcium, magnesium, iron, and other metals. The result of using chelating agents is to increase the cleaning …